Herpes Zoster


PUBLISHED: 2014 CATEGORY: Health care providers, Adults, Seniors TYPE: External Link Update on the Use of Herpes Zoster Vaccine

Update on the Use of Herpes Zoster Vaccine

Since the development of the 2010 statement, new data has been published with regards to the administration and safety of herpes zoster vaccine. n order to inform the recommendations of the National Advisory Committee on Immunization (NACI) made in this update, a systematic review of the literature was undertaken. This review focused on emerging literature since the previous statement as well as specific areas highlighted for review. Articles were obtained using a PubMed search from August 31, 2008 to September 30, 2012. Recommendations and llevels of evidence evaluations were agreed to by consensus of NACI members and were based on previously published NACI guidelines.

Authors: National Advisory Committee on Immunization
Corporate Authors: National Advisory Committee on Immunization
Publisher: Public Health Agency of Canada

PUBLISHED: 2013 CATEGORY: Adults, Seniors TYPE: External Link Fact Sheet – Shingles (Herpes Zoster)

Fact Sheet – Shingles (Herpes Zoster)

This fact sheet provides information on shingles (herpes zoster), symptoms, risks, protection, and treatment.

Corporate Authors: Public Health Agency of Canada
Publisher: Public Health Agency of Canada

PUBLISHED: 2013 CATEGORY: TYPE: External Link Feuille de renseignements – Zona (herpès zoster)

Feuille de renseignements – Zona (herpès zoster)

Cette feuille de renseignements offre des informations sur le zona (herpès zoster), les symptômes, les risques, la protection contre le zona, et le traitement.

Corporate Authors: Agence de la santé publique du Canada
Publisher: Agence de la santé publique du Canada

PUBLISHED: 2011 CATEGORY: Health care providers TYPE: External Link Update on herpes zoster vaccination: A family practitioner's guide

Update on herpes zoster vaccination: A family practitioner's guide

The objective of this Update is to answer frequently asked questions surrounding the use of the herpes zoster (shingles) vaccine.

Authors: Shapiro M et al.
Journal Issue: 10
Journal Title: Canadian Family Physician
Journal Volume: 57
Publisher: College of Family Physicians of Canada

PUBLISHED: 2010 CATEGORY: TYPE: External Link Déclaration sur l'utilisation recommandée du vaccin contre le virus de l'herpès zoster

Déclaration sur l'utilisation recommandée du vaccin contre le virus de l'herpès zoster

La présente déclaration fournit des recommandations pour l’utilisation de ZostavaxMC chez les adultes canadiens. À mesure que de nouveaux renseignements concernant ZostavaxMC et le fardeau de la maladie seront accessibles, ces recommandations seront révisées. Les questions relatives à la rentabilité, à l’acceptabilité et à la faisabilité des programmes de vaccination seront étudiées par d’autres groupes provinciaux ou fédéraux.

Corporate Authors: Comité consultatif national de l'immunisation
Journal Issue: DCC-1
Journal Title: Relevé des maladies transmissibles au Canada
Journal Volume: 36
Publisher: Agence de la santé publique du Canada

PUBLISHED: 2010 CATEGORY: Health care providers, Adults, Seniors TYPE: External Link Statement on the recommended use of Herpes zoster vaccine

Statement on the recommended use of Herpes zoster vaccine

This statement provides recommendations for use of Zostavax™ in Canadian adults. As new information regarding Zostavax™ and/or the burden of illness becomes available, the recommendations will be reviewed. Issues including cost-effectiveness, acceptability of vaccine programs, and feasibility will be addressed by other provincial or federal groups.

Corporate Authors: National Advisory Committee on Immunization
Journal Issue: ACS-1
Journal Title: Canada Communicable Disease Report
Journal Volume: 36
Publisher: Public Health Agency of Canada